期刊文献+

黄体酮透皮给药系统体外经皮渗透特性的研究 被引量:7

Studies on permeation of transdermal progesterone delivery system in vitro
下载PDF
导出
摘要 目的研究黄体酮透皮给药系统的体外经皮渗透特性。方法采用聚丙烯酸酯为骨架制备黄体酮透皮贴片,以离体人皮为透皮模型,采用Valia-Chien扩散池和高效液相色谱法研究促渗剂、药物含量对黄体酮透皮给药系统经皮渗透的影响。结果23%单月桂酸甘油酯与15%棕榈酸乙酯合用对黄体酮促渗效果明显,经皮渗透速率为1.50±0.64μg·cm-2·h-1,增渗倍数达到了21.4倍。贴片中黄体酮含量由0.75mg·cm-2提高到1.0mg·cm-2时,经皮渗透速率明显增大;含量提高到1.25mg·cm-2时,经皮渗透速率无明显变化。结论单月桂酸甘油酯和棕榈酸乙酯联用对黄体酮透皮给药系统体外经皮渗透具有显著的促进作用,黄体酮的最佳含量是1.0mg·cm-2。 AIM: To study the permeation of transdermal progesterone delivery, system in vitro. METHODS: The polyacrylic matrix-type transdermal patch of progesterone was prepared. The effect of penetration enhancers and drug content of the patch on the in vitro permeability of progesterone through human skin was examined using Valia-Chien diffusion cell and high performance liquid chromatography. RESULTS: The patch consisting of 23% monolaurin and 15% ethyl palmitate showed the optimal permeation, mean permeation rate being 1.50±0.64 μg·cm^-2·h^-1 with 21.4-fold enhancement, and permeation rate increased significantly with the increase of progesterone content from 0.75 to 1.0 mg·cm^-2, and did not increase further with the increase of content from 1.0 to 1.25 mg·cm^-2 . CONCLUSION: Combination of monolaurin and ethyl palmitate can significantly increase the percutaneous absorptionof transdermal progesterone delivery system, whose optimal contents of progesterone was 1.0 mg·cm^-2.
出处 《中国临床药理学与治疗学》 CAS CSCD 2006年第8期907-910,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 透皮给药系统 压敏胶骨架 透皮促进剂 聚丙烯酸酯 黄体酮 高效液相色谱法 transdermal delivery system pressuresensitive adhesive matrix skin penetration enhancers polyacrylate progesterone high efficiency liquid chromatography
  • 相关文献

参考文献7

二级参考文献13

  • 1关家彦,戴军.布洛芬包结物的研制[J].中国药学杂志,1993,28(6):360-362. 被引量:7
  • 2Weber P,Lütschg J. Methylphenidate treatment[J].Pediapr Neurol,2002,26(4):261-266.
  • 3Panchagnula R.Transdermal delivery of drugs[J].Indian J Pharmacol,1997,29(2): 140-156.
  • 4Fang JY,Hwang TL,Fang CL, et al. In vitro and in vivo evaluations of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug [J]. Int J Pharm, 2003,255(5) :153-166
  • 5Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery [J]. Eur J Pharm Sci, 2001,14(2): 101-114
  • 6Singh P,Boniello S,Liu P, et al. Transdermal iontophoretic delivery of methylphenidate HCl in vitro[J].Int J Pharm, 1999,178(3) 121-128.
  • 7Langer RD. Int J Fertil, 1999;44(21): 67
  • 8Warren MP, Shantha S. Int J Fertil, 1999; 44(21) : 96
  • 9Dorem M. Maturitas, 2000;34(Suppl 1): 17-23
  • 10Deligdisch L. Mod Pathol, 2000;13(3): 285-294

共引文献32

同被引文献138

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部